Upregulated expression of LOX is a novel independent prognostic marker of worse outcome in gastric cancer patients after curative surgery

Oncology Letters

Volumn 5, Issue 3, 2013, Pages 896-902

  Zhang, Qing ^a   Jin, Xiao Shun ^a   Yang, Zhong Yin ^a   Wei, Min ^a   Zhu, Xiao Cheng ^b   Wang, Ping ^a   Liu, Bing Ya ^a   Gu, Qin Long ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; LOX gene; Prognostic marker; Tissue microarray

Indexed keywords

PROTEIN LYSINE 6 OXIDASE;

ADULT; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; STOMACH CANCER; TISSUE MICROARRAY; UPREGULATION;

EID: 84872738927     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1092     Document Type: Article

References (29)

1. Panchenko MV, Stetler-Stevenson WG, Trubetskoy OV, GacheruSN and Kagan HM: Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase: Potential role of procollagen C-proteinase. J Biol Chem 271: 7113-7119, 1996.
2. Csiszar K: Lysyl oxidases: A novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 70: 1-32, 2001.
3. Lucero HA and Kagan HM: Lysyl oxidase: an oxidativeenzyme and effector of cell function. Cell Mol Life Sci 63: 2304-2316, 2006.
4. Pinnell SR and Martin GR: The cross-linking of collagen and elastin: enzymatic conversion of lysine in peptide linkage to alpha-aminoadipic-delta-semialdehyde (allysine) by an extract from bone. Proc Natl Acad Sci USA 61: 708-716, 1968.
5. Khakoo A, Thomas R, Trompeter R, Duffy P, Price R and PopeFM: Congenital cutis laxa and lysyl oxidase deficiency. Clin Genet 51: 109-114, 1997.
6. Royce PM, Camakaris J and Danks DM: Reduced lysyl oxidase activity in skin fibroblasts from patients with Menkes' syndrome. Biochem J 192: 579-586, 1980.
7. Sibon I, Sommer P, Lamaziere JM and Bonnet J: Lysyl oxidase deficiency: a new cause of human arterial dissection. Heart 91: e33, 2005.
8. Kagan HM, Raghavan J and Hollander W: Changes in aortic lysyl oxidase activity in diet-induced atherosclerosis in the rabbit. Arteriosclerosis 1: 287-291, 1981.
9. Kagan HM: Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis. Pathol Res Prac 190: 910-919, 1994.
10. Gilad GM, Kagan HM and Gilad VH: Evidence for increased lysyl oxidase, the extracellular matrix-forming enzyme, in Alzheimer's disease brain. Neurosci Lett 376: 210-214, 2005.
11. Payne SL, Hendrix MJ and Kirschmann DA: Paradoxical roles for lysyl oxidases in cancer-a prospect. Cell Biochem 101: 1338-1354, 2007.
12. Kaneda A, Wakazono K, Tsukamoto T, et al: Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res 64: 6410-6415, 2004.
13. Payne SL, Fogelgren B, Hess AR, et al: Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res 65: 11429-11436, 2005.
14. Kelley JR and Duggan JM: Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56: 1-9, 2003.
15. Cunningham D, Allum WH, Stenning SP, et al; MAGIC Trial Participants: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New Eng J Med 355: 11-20, 2006.
16. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Eng J Med 345: 725-730, 2001.
17. Scartozzi M, Galizia E, Freddari F, Berardi R, Cellerino R and Cascinu S: Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. Cancer Treat Rev 30: 451-459, 2004.
18. Sobin LH and Wittekind C: TNM Classification of Malignant Tumors. 6th edition. Wiley-Liss, New York, 2002.
19. Ajani J, D'Amico TA, Hayman JA, Meropol NJ and MinskyB; National Comprehensive Cancer Network. Gastric cancer: Clinical practice guidelines in oncology. J Natl Compr Canc Netw 1: 28-39, 2003.
20. Xu C, Zheng P, Shen S, et al: NMR structure and regulated expression in APL cell of human SH3BGRL3. FEBS Lett 579: 2788-2794, 2005.
21. Kagan HM and Li W: Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 88: 660-672, 2003.
22. Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nat Med 10: 789-799, 2004.
23. Bouez C, Reynaud C, Noblesse E, et al: The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model. Clin Cancer Res 12: 1463-1469, 2006.
24. Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-903, 2006.
25. Erler JT, Bennewith KL, Nicolau M, et al: Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222-1226, 2006.
26. Lapointe J, Li C, Higgins JP, et al: Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 101: 811-816, 2004.
27. Stassar MJ, Devitt G, Brosius M, et al: Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer 85: 1372-1382, 2001.
28. Wilgus ML, Borczuk AC, Stoopler M, Ginsburg M, Gorenstein L, Sonett JR and Powell CA: Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival. Cancer 117: 2186-2191, 2011.
29. Li W, Nellaiappan K, Strassmaier T, Graham L, Thomas KM and Kagan HM: Localization and activity of lysyl oxidase within nuclei of fibrogenic cells. Proc Natl Acad Sci USA 94: 12817-12822, 1997.